secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K/A
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001628280-24-047098
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beauty Health terminates CRO Daniel Watson without cause; $430K severance, RSU acceleration
--------------------------------------------------------------------------------

- Chief Revenue Officer Daniel Watson terminated without cause effective Oct 14, 2024; advisory role through Jan 1, 2025.
- Receives $430K cash severance over 12 months, plus accelerated vesting of 329,251 RSUs.
- Will serve as consultant Jan-Mar 2025 at $40K/month; non-compete through March 2026.
- Separation Agreement filed; Watson releases all claims against the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024047098/0001628280-24-047098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024047098/skin-20241008.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-047098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer